1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pharmaceutical Intermediates Consumption 2015-2025

2.1.2 Pharmaceutical Intermediates Consumption CAGR by Region

2.2 Pharmaceutical Intermediates Segment by Type

2.2.1 GMP

2.2.2 Non-GMP

2.3 Pharmaceutical Intermediates Consumption by Type

2.3.1 Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

2.3.2 Global Pharmaceutical Intermediates Revenue and Market Share by Type (2015-2020)

2.3.3 Global Pharmaceutical Intermediates Sale Price by Type (2015-2020)

2.4 Pharmaceutical Intermediates Segment by Application

2.4.1 Antibiotics

2.4.2 Antipyretic Analgesics

2.4.3 Vitamins

2.4.4 Others

2.5 Pharmaceutical Intermediates Consumption by Application

2.5.1 Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

2.5.2 Global Pharmaceutical Intermediates Value and Market Share by Type (2015-2020)

2.5.3 Global Pharmaceutical Intermediates Sale Price by Type (2015-2020)

3 Global Pharmaceutical Intermediates by Company

3.1 Global Pharmaceutical Intermediates Sales Market Share by Company

3.1.1 Global Pharmaceutical Intermediates Sales by Company (2018-2020)

3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Company (2018-2020)

3.2 Global Pharmaceutical Intermediates Revenue Market Share by Company

3.2.1 Global Pharmaceutical Intermediates Revenue by Company (2018-2020)

3.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Company (2018-2020)

3.3 Global Pharmaceutical Intermediates Sale Price by Company

3.4 Global Pharmaceutical Intermediates Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Pharmaceutical Intermediates Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Pharmaceutical Intermediates Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Pharmaceutical Intermediates by Regions

4.1 Pharmaceutical Intermediates by Regions

4.2 Americas Pharmaceutical Intermediates Consumption Growth

4.3 APAC Pharmaceutical Intermediates Consumption Growth

4.4 Europe Pharmaceutical Intermediates Consumption Growth

4.5 Middle East & Africa Pharmaceutical Intermediates Consumption Growth

5 Americas

5.1 Americas Pharmaceutical Intermediates Consumption by Countries

5.1.1 Americas Pharmaceutical Intermediates Consumption by Countries (2015-2020)

5.1.2 Americas Pharmaceutical Intermediates Value by Countries (2015-2020)

5.2 Americas Pharmaceutical Intermediates Consumption by Type

5.3 Americas Pharmaceutical Intermediates Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Pharmaceutical Intermediates Consumption by Regions

6.1.1 APAC Pharmaceutical Intermediates Consumption by Regions (2015-2020)

6.1.2 APAC Pharmaceutical Intermediates Value by Regions (2015-2020)

6.2 APAC Pharmaceutical Intermediates Consumption by Type

6.3 APAC Pharmaceutical Intermediates Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Pharmaceutical Intermediates by Countries

7.1.1 Europe Pharmaceutical Intermediates Consumption by Countries (2015-2020)

7.1.2 Europe Pharmaceutical Intermediates Value by Countries (2015-2020)

7.2 Europe Pharmaceutical Intermediates Consumption by Type

7.3 Europe Pharmaceutical Intermediates Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Pharmaceutical Intermediates by Countries

8.1.1 Middle East & Africa Pharmaceutical Intermediates Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Pharmaceutical Intermediates Value by Countries (2015-2020)

8.2 Middle East & Africa Pharmaceutical Intermediates Consumption by Type

8.3 Middle East & Africa Pharmaceutical Intermediates Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Pharmaceutical Intermediates Distributors

10.3 Pharmaceutical Intermediates Customer

11 Global Pharmaceutical Intermediates Market Forecast

11.1 Global Pharmaceutical Intermediates Consumption Forecast (2021-2025)

11.2 Global Pharmaceutical Intermediates Forecast by Regions

11.2.1 Global Pharmaceutical Intermediates Forecast by Regions (2021-2025)

11.2.2 Global Pharmaceutical Intermediates Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Pharmaceutical Intermediates Forecast by Type

11.8 Global Pharmaceutical Intermediates Forecast by Application

12 Key Players Analysis

12.1 Lonza

12.1.1 Company Information

12.1.2 Pharmaceutical Intermediates Product Offered

12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Lonza Latest Developments

12.2 Lianhetech

12.2.1 Company Information

12.2.2 Pharmaceutical Intermediates Product Offered

12.2.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Lianhetech Latest Developments

12.3 Catalent

12.3.1 Company Information

12.3.2 Pharmaceutical Intermediates Product Offered

12.3.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Catalent Latest Developments

12.4 Jubilant

12.4.1 Company Information

12.4.2 Pharmaceutical Intermediates Product Offered

12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Jubilant Latest Developments

12.5 Granules

12.5.1 Company Information

12.5.2 Pharmaceutical Intermediates Product Offered

12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Granules Latest Developments

12.6 Patheon

12.6.1 Company Information

12.6.2 Pharmaceutical Intermediates Product Offered

12.6.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Patheon Latest Developments

12.7 BASF

12.7.1 Company Information

12.7.2 Pharmaceutical Intermediates Product Offered

12.7.3 BASF Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 BASF Latest Developments

12.8 Ganesh

12.8.1 Company Information

12.8.2 Pharmaceutical Intermediates Product Offered

12.8.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Ganesh Latest Developments

12.9 Porton

12.9.1 Company Information

12.9.2 Pharmaceutical Intermediates Product Offered

12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Porton Latest Developments

12.10 Chemcon

12.10.1 Company Information

12.10.2 Pharmaceutical Intermediates Product Offered

12.10.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Chemcon Latest Developments

12.11 Yongtai

12.11.1 Company Information

12.11.2 Pharmaceutical Intermediates Product Offered

12.11.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Yongtai Latest Developments

12.12 ABA Chem

12.12.1 Company Information

12.12.2 Pharmaceutical Intermediates Product Offered

12.12.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 ABA Chem Latest Developments

12.13 Alpha

12.13.1 Company Information

12.13.2 Pharmaceutical Intermediates Product Offered

12.13.3 Alpha Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Alpha Latest Developments

12.14 Jiujiujiu

12.14.1 Company Information

12.14.2 Pharmaceutical Intermediates Product Offered

12.14.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Jiujiujiu Latest Developments

12.15 Jiuzhou

12.15.1 Company Information

12.15.2 Pharmaceutical Intermediates Product Offered

12.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 Jiuzhou Latest Developments

12.16 Tianma

12.16.1 Company Information

12.16.2 Pharmaceutical Intermediates Product Offered

12.16.3 Tianma Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2018-2020)

12.16.4 Main Business Overview

12.16.5 Tianma Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Pharmaceutical Intermediates Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of GMP

Table 5. Major Players of Non-GMP

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

Table 8. Global Pharmaceutical Intermediates Revenue by Type (2015-2020) ($ million)

Table 9. Global Pharmaceutical Intermediates Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Pharmaceutical Intermediates Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)

Table 13. Global Pharmaceutical Intermediates Value by Application (2015-2020)

Table 14. Global Pharmaceutical Intermediates Value Market Share by Application (2015-2020)

Table 15. Global Pharmaceutical Intermediates Sale Price by Application (2015-2020)

Table 16. Global Pharmaceutical Intermediates Sales by Company (2017-2019) (K MT)

Table 17. Global Pharmaceutical Intermediates Sales Market Share by Company (2017-2019)

Table 18. Global Pharmaceutical Intermediates Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Pharmaceutical Intermediates Revenue Market Share by Company (2017-2019)

Table 20. Global Pharmaceutical Intermediates Sale Price by Company (2017-2019)

Table 21. Global Pharmaceutical Intermediates Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Pharmaceutical Intermediates Products Offered

Table 23. Pharmaceutical Intermediates Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Pharmaceutical Intermediates Consumption by Regions 2015-2020 (K MT)

Table 25. Global Pharmaceutical Intermediates Consumption Market Share by Regions 2015-2020

Table 26. Global Pharmaceutical Intermediates Value by Regions 2015-2020 ($ Millions)

Table 27. Global Pharmaceutical Intermediates Value Market Share by Regions 2015-2020

Table 28. Americas Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)

Table 29. Americas Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)

Table 30. Americas Pharmaceutical Intermediates Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Pharmaceutical Intermediates Value Market Share by Countries (2015-2020)

Table 32. Americas Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)

Table 33. Americas Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

Table 34. Americas Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)

Table 35. Americas Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)

Table 36. APAC Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)

Table 37. APAC Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)

Table 38. APAC Pharmaceutical Intermediates Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Pharmaceutical Intermediates Value Market Share by Regions (2015-2020)

Table 40. APAC Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)

Table 41. APAC Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

Table 42. APAC Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)

Table 43. APAC Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)

Table 44. Europe Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)

Table 45. Europe Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)

Table 46. Europe Pharmaceutical Intermediates Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Pharmaceutical Intermediates Value Market Share by Countries (2015-2020)

Table 48. Europe Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)

Table 49. Europe Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

Table 50. Europe Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)

Table 51. Europe Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Pharmaceutical Intermediates Consumption by Countries (2015-2020) (K MT)

Table 53. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Pharmaceutical Intermediates Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Pharmaceutical Intermediates Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Pharmaceutical Intermediates Consumption by Type (2015-2020) (K MT)

Table 57. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Pharmaceutical Intermediates Consumption by Application (2015-2020) (K MT)

Table 59. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)

Table 60. Pharmaceutical Intermediates Distributors List

Table 61. Pharmaceutical Intermediates Customer List

Table 62. Global Pharmaceutical Intermediates Consumption Forecast by Countries (2021-2025) (K MT)

Table 63. Global Pharmaceutical Intermediates Consumption Market Forecast by Regions

Table 64. Global Pharmaceutical Intermediates Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Pharmaceutical Intermediates Value Market Share Forecast by Regions

Table 66. Global Pharmaceutical Intermediates Consumption Forecast by Type (2021-2025) (K MT)

Table 67. Global Pharmaceutical Intermediates Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Pharmaceutical Intermediates Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Pharmaceutical Intermediates Value Market Share Forecast by Type (2021-2025)

Table 70. Global Pharmaceutical Intermediates Consumption Forecast by Application (2021-2025) (K MT)

Table 71. Global Pharmaceutical Intermediates Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Pharmaceutical Intermediates Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Pharmaceutical Intermediates Value Market Share Forecast by Application (2021-2025)

Table 74. Lonza Product Offered

Table 75. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 76. Lonza Main Business

Table 77. Lonza Latest Developments

Table 78. Lonza Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 79. Lianhetech Product Offered

Table 80. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 81. Lianhetech Main Business

Table 82. Lianhetech Latest Developments

Table 83. Lianhetech Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 84. Catalent Product Offered

Table 85. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 86. Catalent Main Business

Table 87. Catalent Latest Developments

Table 88. Catalent Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 89. Jubilant Product Offered

Table 90. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 91. Jubilant Main Business

Table 92. Jubilant Latest Developments

Table 93. Jubilant Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 94. Granules Product Offered

Table 95. Granules Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 96. Granules Main Business

Table 97. Granules Latest Developments

Table 98. Granules Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 99. Patheon Product Offered

Table 100. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 101. Patheon Main Business

Table 102. Patheon Latest Developments

Table 103. Patheon Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 104. BASF Product Offered

Table 105. BASF Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 106. BASF Main Business

Table 107. BASF Latest Developments

Table 108. BASF Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 109. Ganesh Product Offered

Table 110. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 111. Ganesh Main Business

Table 112. Ganesh Latest Developments

Table 113. Ganesh Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 114. Porton Product Offered

Table 115. Porton Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 116. Porton Main Business

Table 117. Porton Latest Developments

Table 118. Porton Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 119. Chemcon Product Offered

Table 120. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 121. Chemcon Main Business

Table 122. Chemcon Latest Developments

Table 123. Chemcon Basic Information, Company Total Revenue (in $ million), Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors

Table 124. Yongtai Product Offered

Table 125. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 126. Yongtai Main Business

Table 127. Yongtai Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 128. Yongtai Latest Developments

Table 129. ABA Chem Product Offered

Table 130. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 131. ABA Chem Main Business

Table 132. ABA Chem Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 133. ABA Chem Latest Developments

Table 134. Alpha Product Offered

Table 135. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 136. Alpha Main Business

Table 137. Alpha Latest Developments

Table 138. Alpha Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 139. Jiujiujiu Product Offered

Table 140. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 141. Jiujiujiu Main Business

Table 142. Jiujiujiu Latest Developments

Table 143. Jiujiujiu Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 144. Jiuzhou Product Offered

Table 145. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 146. Jiuzhou Main Business

Table 147. Jiuzhou Latest Developments

Table 148. Jiuzhou Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 149. Tianma Product Offered

Table 150. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 151. Tianma Main Business

Table 152. Tianma Latest Developments

Table 153. Tianma Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Pharmaceutical Intermediates

Figure 2. Pharmaceutical Intermediates Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Pharmaceutical Intermediates Consumption Growth Rate 2015-2025 (K MT)

Figure 5. Global Pharmaceutical Intermediates Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of GMP

Figure 7. Product Picture of Non-GMP

Figure 8. Global Pharmaceutical Intermediates Consumption Market Share by Type (2015-2020)

Figure 9. Global Pharmaceutical Intermediates Value Market Share by Type (2015-2020)

Figure 10. Pharmaceutical Intermediates Consumed in Antibiotics

Figure 11. Global Pharmaceutical Intermediates Market: Antibiotics (2015-2020) (K MT)

Figure 12. Global Pharmaceutical Intermediates Market: Antibiotics (2015-2020) ($ Millions)

Figure 13. Pharmaceutical Intermediates Consumed in Antipyretic Analgesics

Figure 14. Global Pharmaceutical Intermediates Market: Antipyretic Analgesics (2015-2020) (K MT)

Figure 15. Global Pharmaceutical Intermediates Market: Antipyretic Analgesics (2015-2020) ($ Millions)

Figure 16. Pharmaceutical Intermediates Consumed in Vitamins

Figure 17. Global Pharmaceutical Intermediates Market: Vitamins (2015-2020) (K MT)

Figure 18. Global Pharmaceutical Intermediates Market: Vitamins (2015-2020) ($ Millions)

Figure 19. Pharmaceutical Intermediates Consumed in Others

Figure 20. Global Pharmaceutical Intermediates Market: Others (2015-2020) (K MT)

Figure 21. Global Pharmaceutical Intermediates Market: Others (2015-2020) ($ Millions)

Figure 22. Global Pharmaceutical Intermediates Consumption Market Share by Application (2015-2020)

Figure 23. Global Pharmaceutical Intermediates Value Market Share by Application (2015-2020)

Figure 24. Global Pharmaceutical Intermediates Sales Market Share by Company in 2017

Figure 25. Global Pharmaceutical Intermediates Sales Market Share by Company in 2019

Figure 26. Global Pharmaceutical Intermediates Revenue Market Share by Company in 2017

Figure 27. Global Pharmaceutical Intermediates Revenue Market Share by Company in 2019

Figure 28. Global Pharmaceutical Intermediates Sale Price by Company in 2019

Figure 29. Global Pharmaceutical Intermediates Consumption Market Share by Regions 2015-2020

Figure 30. Global Pharmaceutical Intermediates Value Market Share by Regions 2015-2020

Figure 31. Americas Pharmaceutical Intermediates Consumption 2015-2020 (K MT)

Figure 32. Americas Pharmaceutical Intermediates Value 2015-2020 ($ Millions)

Figure 33. APAC Pharmaceutical Intermediates Consumption 2015-2020 (K MT)

Figure 34. APAC Pharmaceutical Intermediates Value 2015-2020 ($ Millions)

Figure 35. Europe Pharmaceutical Intermediates Consumption 2015-2020 (K MT)

Figure 36. Europe Pharmaceutical Intermediates Value 2015-2020 ($ Millions)

Figure 37. Middle East & Africa Pharmaceutical Intermediates Consumption 2015-2020 (K MT)

Figure 38. Middle East & Africa Pharmaceutical Intermediates Value 2015-2020 ($ Millions)

Figure 39. Americas Pharmaceutical Intermediates Consumption Market Share by Countries in 2019

Figure 40. Americas Pharmaceutical Intermediates Value Market Share by Countries in 2019

Figure 41. Americas Pharmaceutical Intermediates Consumption Market Share by Type in 2019

Figure 42. Americas Pharmaceutical Intermediates Consumption Market Share by Application in 2019

Figure 43. United States Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 44. United States Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 45. Canada Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 46. Canada Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 47. Mexico Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 48. Mexico Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 49. APAC Pharmaceutical Intermediates Consumption Market Share by Countries in 2019

Figure 50. APAC Pharmaceutical Intermediates Value Market Share by Regions in 2019

Figure 51. APAC Pharmaceutical Intermediates Consumption Market Share by Type in 2019

Figure 52. APAC Pharmaceutical Intermediates Consumption Market Share by Application in 2019

Figure 53. China Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 54. China Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 55. Japan Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 56. Japan Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 57. Korea Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 58. Korea Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 59. Southeast Asia Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 60. Southeast Asia Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 61. India Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 62. India Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 63. Australia Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 64. Australia Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 65. Europe Pharmaceutical Intermediates Consumption Market Share by Countries in 2019

Figure 66. Europe Pharmaceutical Intermediates Value Market Share by Countries in 2019

Figure 67. Europe Pharmaceutical Intermediates Consumption Market Share by Type in 2019

Figure 68. Europe Pharmaceutical Intermediates Consumption Market Share by Application in 2019

Figure 69. Germany Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 70. Germany Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 71. France Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 72. France Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 73. UK Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 74. UK Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 75. Italy Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 76. Italy Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 77. Russia Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 78. Russia Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 79. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Countries in 2019

Figure 80. Middle East & Africa Pharmaceutical Intermediates Value Market Share by Countries in 2019

Figure 81. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Type in 2019

Figure 82. Middle East & Africa Pharmaceutical Intermediates Consumption Market Share by Application in 2019

Figure 83. Egypt Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 84. Egypt Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 85. South Africa Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 86. South Africa Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 87. Israel Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 88. Israel Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 89. Turkey Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 90. Turkey Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 91. GCC Countries Pharmaceutical Intermediates Consumption Growth 2015-2020 (K MT)

Figure 92. GCC Countries Pharmaceutical Intermediates Value Growth 2015-2020 ($ Millions)

Figure 93. Global Pharmaceutical Intermediates Consumption Growth Rate Forecast (2021-2025) (K MT)

Figure 94. Global Pharmaceutical Intermediates Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 95. Americas Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 96. Americas Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 97. APAC Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 98. APAC Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 99. Europe Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 100. Europe Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 101. Middle East & Africa Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 102. Middle East & Africa Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 103. United States Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 104. United States Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 105. Canada Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 106. Canada Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 107. Mexico Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 108. Mexico Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 109. Brazil Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 110. Brazil Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 111. China Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 112. China Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 113. Japan Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 114. Japan Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 115. Korea Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 116. Korea Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 117. Southeast Asia Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 118. Southeast Asia Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 119. India Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 120. India Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 121. Australia Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 122. Australia Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 123. Germany Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 124. Germany Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 125. France Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 126. France Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 127. UK Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 128. UK Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 129. Italy Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 130. Italy Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 131. Russia Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 132. Russia Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 133. Spain Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 134. Spain Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 135. Egypt Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 136. Egypt Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 137. South Africa Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 138. South Africa Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 139. Israel Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 140. Israel Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 141. Turkey Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 142. Turkey Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 143. GCC Countries Pharmaceutical Intermediates Consumption 2021-2025 (K MT)

Figure 144. GCC Countries Pharmaceutical Intermediates Value 2021-2025 ($ Millions)

Figure 145. Lonza Pharmaceutical Intermediates Market Share (2018-2020)

Figure 146. Lianhetech Pharmaceutical Intermediates Market Share (2018-2020)

Figure 147. Catalent Pharmaceutical Intermediates Market Share (2018-2020)

Figure 148. Jubilant Pharmaceutical Intermediates Market Share (2018-2020)

Figure 149. Granules Pharmaceutical Intermediates Market Share (2018-2020)

Figure 150. Patheon Pharmaceutical Intermediates Market Share (2018-2020)

Figure 151. BASF Pharmaceutical Intermediates Market Share (2018-2020)

Figure 152. Ganesh Pharmaceutical Intermediates Market Share (2018-2020)

Figure 153. Porton Pharmaceutical Intermediates Market Share (2018-2020)

Figure 154. Chemcon Pharmaceutical Intermediates Market Share (2018-2020)

Figure 155. Yongtai Pharmaceutical Intermediates Market Share (2018-2020)

Figure 156. ABA Chem Pharmaceutical Intermediates Market Share (2018-2020)

Figure 157. Alpha Pharmaceutical Intermediates Market Share (2018-2020)

Figure 158. Jiujiujiu Pharmaceutical Intermediates Market Share (2018-2020)

Figure 159. Jiuzhou Pharmaceutical Intermediates Market Share (2018-2020)

Figure 160. Tianma Pharmaceutical Intermediates Market Share (2018-2020)